Related Experiment Video

Updated: Jul 14, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

[Potential role of NK cells in future anti-tumor immunotherapies]

Alexandre Iannello1, Olfa Débbeche, Suzanne Samarani

  • 1Centre de Recherche de l'Hôpital Sainte-Justine, L'Axe du Cancer et Maladies Virales et Immunitaires, Département de Microbiologie et d'Immunologie, Université de Montréal, Montréal, Québec, Canada.

Medecine Sciences : M/S
|May 16, 2007
PubMed

Insights

Natural Killer (NK) cells are potent immune cells that target tumors and infections. Research is advancing NK cell therapy for leukemia and exploring its potential against solid tumors.

Area of Science:

  • Immunology
  • Cell Biology

Context:

  • Natural Killer (NK) cells, once underestimated, are now recognized for their crucial role in immune surveillance.
  • Significant advancements in understanding NK cell biology, including their recognition and cytotoxic mechanisms, have occurred over the past decade.

Purpose:

  • To review the biological basis and clinical applications of Natural Killer (NK) cell-based immunotherapies.
  • To discuss the challenges and future directions for utilizing NK cells in treating various diseases, particularly solid tumors.

Summary:

  • NK cells possess inherent capabilities to identify and eliminate tumor and virus-infected cells.
  • Progress in understanding NK cell mechanisms has enabled their use as immunotherapeutic agents, notably in bone marrow transplantation for leukemia.
  • The application of NK cell therapy for solid tumors remains an area with significant untapped potential.

Impact:

  • NK cell research is driving novel immunotherapeutic strategies for challenging diseases.
  • Understanding NK cell function is key to overcoming limitations in their clinical application.
  • This review highlights the therapeutic promise of NK cells and the ongoing research to fully harness their potential in cancer treatment.

More Related Videos

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...